We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

This study has been terminated.
(Early termination of patient enrollment based on business decision)
ClinicalTrials.gov Identifier:
First Posted: March 4, 2009
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Cordis Corporation
To assess the safety and effecacy of the Cypher stent ™ & Cypher Select ™ in the normal use of medical practices, within the labeled indications.

Condition Intervention Phase
Coronary Artery Disease Device: Cypher stent ™ or Cypher Select ™ Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: French Post-Marketing Surveillance Survey

Further study details as provided by Cordis Corporation:

Primary Outcome Measures:
  • There is no pre-specified endpoint. [ Time Frame: 12 Months ]

Enrollment: 4080
Study Start Date: May 2006
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Cypher drug-eluting stent
Device: Cypher stent ™ or Cypher Select ™
Cypher drug-eluting stent

Detailed Description:
Multi-center, retrospective and prospective French register. This register does not impose any constraint on the evaluated population, the procedure, or the required examinations. The local practice routines should be applied.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with symptomatic ischemic heart disease due to de novo lesions (lesions <30 mm vessel reference diameter of 2.25 mm to 5 mm), assessed visually, native coronary arteries.

Exclusion Criteria:

  • Patients suffering from coronary heart disease.
  • Patients for whom treatment antiplatelet and / or anticoagulant is against the state;
  • Patients with injuries incompatible with the full inflation of a balloon angioplasty;
  • Transplant patients ;
  • Patients with known allergy to Sirolimus, the stainless steel 316L, to polymethacrylates or copolymers polyolefins;
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Dr. Hans Peter Stoll, MD, Cordis
ClinicalTrials.gov Identifier: NCT00855478     History of Changes
Other Study ID Numbers: 05-FR-002
First Submitted: March 3, 2009
First Posted: March 4, 2009
Last Update Posted: October 12, 2017
Last Verified: November 2010

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases